RxSight, Inc. (RXST) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 231 transactions totaling $80.2M, demonstrating a bearish sentiment with -$35.5M in net insider flow. The most recent transaction on Sep 25, 2025 involved a transaction of 15,096 shares valued at $65.5K.
No significant insider buying has been recorded for RXST in the recent period.
No significant insider selling has been recorded for RXST in the recent period.
Based on recent SEC filings, insider sentiment for RXST is bearish with an Insider Alignment Score of 28/100 and a net flow of -$35.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at RxSight, Inc. (RXST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading RXST stock, having executed 231 transactions in the past 90 days. The most active insider is Bakker Juliet Tammenoms (Executive), who has made 35 transactions totaling $47.6M.
Get notified when executives and directors at RXST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 25, 2025 | Goldshleger Ilya | Executive | Option Exercise | 15,096 | $4.34 | $65.5K | |
| Sep 25, 2025 | Goldshleger Ilya | Executive | Option Exercise | 8,349 | $4.13 | $34.5K | |
| Jul 31, 2025 | W. Cohen Raymond | Executive | Award | 35,668 | $N/A | $0 | |
| Sep 30, 2024 | Goldshleger Ilya | Executive | Sale | 1,652 | $48.69 | $80.4K | 10b5-1 |
| Sep 30, 2024 | Goldshleger Ilya | Executive | Option Exercise | 3,100 | $15.08 | $46.7K | 10b5-1 |
| Sep 30, 2024 | Goldshleger Ilya | Executive | Sale | 1,448 | $49.38 | $71.5K | 10b5-1 |
| Sep 26, 2024 | Goldshleger Ilya | Executive | Option Exercise | 3,105 | $15.08 | $46.8K | 10b5-1 |
| Sep 26, 2024 | Goldshleger Ilya | Executive | Sale | 3,105 | $49.29 | $153.0K | 10b5-1 |
| Sep 23, 2024 | Goldshleger Ilya | Executive | Sale | 2,950 | $52.62 | $155.2K | 10b5-1 |
| Sep 23, 2024 | Goldshleger Ilya | Executive | Option Exercise | 3,100 | $15.08 | $46.7K | 10b5-1 |
| Sep 23, 2024 | Goldshleger Ilya | Executive | Sale | 150 | $53.53 | $8.0K | 10b5-1 |
| Sep 20, 2024 | Goldshleger Ilya | Executive | Option Exercise | 3,100 | $15.08 | $46.7K | 10b5-1 |
| Sep 20, 2024 | Goldshleger Ilya | Executive | Sale | 3,100 | $53.19 | $164.9K | 10b5-1 |
| Sep 17, 2024 | Goldshleger Ilya | Executive | Option Exercise | 3,100 | $15.08 | $46.7K | 10b5-1 |
| Sep 17, 2024 | Goldshleger Ilya | Executive | Sale | 3,100 | $56.11 | $173.9K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 89 | $57.9M | 68.2% |
Purchase(P) | 22 | $22.3M | 26.3% |
Exercise(M) | 37 | $4.2M | 4.9% |
Award(A) | 37 | $500.0K | 0.6% |
Gift(G) | 5 | $0 | 0.0% |
Other(J) | 34 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insider selling pressure at RxSight, Inc. has increased, with 17 insiders executing 231 transactions across all time. Total sales of $57.9M significantly outpace purchases of $22.3M, resulting in a net outflow of $35.5M. However, 62% of these transactions are pre-scheduled 10b5-1 plans, often used for tax planning or diversification rather than signaling negative outlook.